Company news
LBX Pharmacy Chain Joint Stock Company news in 2025
LBX Pharmacy Chain Joint Stock Company's news releases, calls and decks from 2025, newest first.
Announcement on Return of Raised Funds Temporarily Used to Supplement Current Capital
December 25, 2025
Announcement on Outline of the Q3 2025 Performance Briefing (November 2025)
December 3, 2025
Announcement on Resolutions of the 12th Meeting of the 5th Board of Directors
December 1, 2025
Announcement on Resignation of Director and Election of Employee Director
November 28, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 24, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
November 11, 2025
Announcement on Implementation of Dividend Distribution for Q3
November 5, 2025
Announcement on Revision to Partial Corporate Internal Governance Systems
October 28, 2025
Announcement on Implementing Repurchase and Cancellation of Equity Incentive Restricted Stocks
October 20, 2025
Announcement on Resignation of Senior Management Members
October 10, 2025
Announcement on Outline of the 2025 Semi-annual Performance Briefing (September 2025)
September 30, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 19, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing
September 15, 2025
Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiary
September 8, 2025
Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025
August 25, 2025
Announcement on Early Termination of Shareholding Reduction Plan for Controlling Shareholders and Results of Shareholding Reduction
August 18, 2025
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
August 15, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1%
July 31, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 7, 2025
Announcement on Outline of the Performance Briefing for 2024 and Q1 2025 (June 2025)
July 1, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
June 30, 2025
Announcement on Reply to Letter of Regulatory Inquiry on Information Disclosure of 2024 Annual Report
June 20, 2025
Notice on Convening the 2024 Annual General Meeting
June 9, 2025
Announcement on Cancellation of Some Special Accounts for Raised Funds
May 14, 2025
Announcement on Share Reduction Plan for Shareholders
May 6, 2025
Announcement on Making Provisions for Asset Impairment in 2024
April 29, 2025
Announcement on Returning Idle Raised Funds Used to Temporarily Supplement Current Capital
April 25, 2025
Announcement on Resolution of the 8th Meeting of the 5th Board of Directors
April 11, 2025
Announcement on Release of Pledge of Some Shares of Controlling Shareholder
April 2, 2025
Announcement on Lifting Restrictions and Listing and Circulation for the 2nd Restricted Trading Period of Restricted Stocks Initially Granted in 2022 Restricted Stock Incentive Plan
March 25, 2025
Announcement on Early Return of Some Raised Funds Temporarily Used for Supplementing Current Capital
February 17, 2025
Announcement on the Lifting of Sales Restrictions and Listing and Circulation of Shares during the First Period of Lifting Sales Restrictions of the Reserved Granted Part of the 2022 Restricted Stock Incentive Plan
January 15, 2025
Announcement on Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks
January 7, 2025